Allergy drug found to clear condition but not symptoms of throat disease
A group of Mayo Clinic researchers conducted the first controlled trial of swallowed fluticasone nasal spray (also known as Flonase) on people with the allergic esophageal condition called eosinophilic esophagitis. Research showed that the aerosolized swallowed allergy drug helped treat the cause of the throat condition, but symptoms lingered. The researchers' findings were presented today at the Annual Scientific Meeting of the American College of Gastroenterology in San Antonio.
Eosinophilic esophagitis is a relatively new disease, first noticed in young people, that causes those who have the condition to feel like solid food is sticking in their throat or like they have heartburn. A steroid applied to the esophagus is often used for treatment, but its effectiveness has not been scientifically proven.
For the randomized, double-blind study, 34 adults swallowed either a placebo or aerosolized fluticasone twice a day for six weeks. Fluticasone is used in inhalers and as a nasal spray to treat inflammation in the lungs and sinuses caused by allergies. The drug is a corticosteroid that decreases irritation and swelling and, when used for asthma, allows for easier breathing.
After completing the course of medication, the research volunteers were given questionnaires to assess their symptoms and side effects of the treatment. Their throats were examined with an endoscope and then through biopsies for the presence of eosinophils -- a type of white blood cell that secretes proteins, which researchers suspect causes swallowing problems.
"We had complete histologic remission in 68 percent of the people who took the fluticasone, compared to zero for the placebo," says Jeffrey Alexander, M.D., a Mayo Clinic gastroenterologist and lead author on the study. "From this perspective, fluticasone does get rid of the eosinophils in the esophagus; however, people's symptoms did not improve."
Dr. Alexander attributes the lack of symptom improvement to several confounding factors. "We had a symptom response in 63 percent of the people, but we had a placebo response in
47 percent of the people, which is very high," Dr. Alexander says. "Our experience in clinical practice is that the symptoms do get better. We suspect the lack of symptom response was related to difficulty in assessing intermittent swallowing symptoms with our questionnaire."
The research team has multiple ongoing studies in the diagnosis, pathophysiology and treatment of eosinophilic esophagitis.
Provided by
Mayo Clinic
-
From lemons to lemonade: Reaction uses carbon dioxide to make carbon-based semiconductor,
27 comments
-
Every black hole contains a new universe: A physicist presents a solution to present-day cosmic mysteries,
208 comments
-
New silicon memory chip developed,
16 comments
-
Computing experts unveil superefficient 'inexact' chip,
45 comments
-
SpaceX private rocket blasts off for space station (Update),
39 comments
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
New estimates up dementia rates in mid-income countries
(HealthDay) -- Use of 10/66 dementia diagnosis criteria (10/66) results in an increase in the estimated incidence of dementia in middle-income countries, according to a study published online May 23 in The La ...
Medicine & Health / Alzheimer's disease & dementia
18 minutes ago |
not rated yet |
0
Childhood obesity increases likelihood of a cranial disorder that may cause blindness
Children who are overweight or obese -- particularly older, non-Hispanic white girls -- are more likely to have a neurological disorder known as idiopathic intracranial hypertension, a rare condition that can result in blindness, ...
Medicine & Health / Pediatrics
4 hours ago |
not rated yet |
0
The Goldilocks effect: Babies learn from experiences that are 'just right'
Long before babies understand the story of Goldilocks, they have more than mastered the fairy tale heroine's method of decision-making. Infants ignore information that is too simple or too complex, focusing instead on situations ...
Medicine & Health / Psychology & Psychiatry
11 hours ago |
5 / 5 (4) |
1
|
Color-changing contact lenses to help diabetics (w/ Video)
For the millions of Americans with diabetes, the inconvenient and often painful method of testing blood sugar levels is a way of life. But research and innovative product design by scientists at The University of Akron may ...
17 hours ago |
4.2 / 5 (5) |
3
|
Stem-cell-growing surface enables bone repair
University of Michigan researchers have proven that a special surface, free of biological contaminants, allows adult-derived stem cells to thrive and transform into multiple cell types. Their success brings stem cell therapies ...
Medicine & Health / Medical research
13 hours ago |
5 / 5 (7) |
1
|
Yahoo seeks to shake up search, Web browsing
(AP) -- Joining the battle to redefine Internet search, Yahoo is taking aim with a new browser enhancement it calls "Axis."
Forensic sleuth probes fate of royal lovers and lion hearts
The French media like to call him the "Indiana Jones of the graveyards", but perhaps a better tag would be the Sherlock Holmes of forensic science.
Deep sea animals stowaway on submarines and reach new territory
Marine scientists studying life around deep-sea vents have discovered that some hardy species can survive the extreme change in pressure that occurs when a research submersible rises to the surface. The team's ...
Good vibes: Coupling electron spin states and carbon nanotube vibrations
(Phys.org) -- An electron’s spin is separate from its motion, and is suitable for use in both highly-precise magnetic sensing as well as a qubit in quantum computing. Recently, scientists at the University ...
New inexpensive, environmentally friendly solar cell shines with potential
The limitations of conventional and current solar cells include high production cost, low operating efficiency and durability, and many cells rely on toxic and scarce materials. Northwestern University researchers have developed ...